OBJECTIVE We describe four patients with ovarian hyperthecosis and the
effects of gonadotrophin releasing hormone on clinical and metabolic
variables. DESIGN Open out-patient study. PATIENTS Four women presente
d with post-menopausal hirsuties. They had significant hair growth acr
oss the chest, upper back and shoulders. Three had histologically prov
en ovarian hyperthecosis and a fourth had large ovaries visualized on
ultrasound. All four women had pronounced risk factors for vascular di
sease; hypertension, hyperlipidaemia and glucose intolerance, and thre
e had already developed symptomatic vascular disease. RESULTS Gonadotr
ophin releasing hormone agonist therapy resulted in significant reduct
ion in plasma androgens and cosmetic reduction in hair growth but had
no effect on hyperlipidaemia. CONCLUSION The post-menopausal women des
cribed in this report were clinically considered to have hyperandrogen
ism due to the pathological pattern of marked body hair over the upper
trunk, Treatment with GnRH was very effective at reducing the severit
y of the hirsuties. The post-menopausal women with hyperthecosis in th
is report had a high prevalence of cardiovascular disease. Since hyper
androgenism and insulin are considered risk factors for cardiovascular
disease in premenopausal women with polycystic ovaries, we discuss th
e possible relationship between insulin and the post-menopausal ovary.